CHELATED CHROMIUM 200 MCG 200 MCG
CHROMIUM (CHROMIUM HVP CHELATE) : 200 MCG · DIN 02236899 · WN PHARMACEUTICALS LTD.
Health Canada status: CANCELLED POST MARKET
What is CHELATED CHROMIUM 200 MCG?
CHELATED CHROMIUM 200 MCG 200 MCG contains CHROMIUM (CHROMIUM HVP CHELATE) : 200 MCG. It is listed in the Health Canada Drug Product Database under DIN 02236899, held by WN PHARMACEUTICALS LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 17-Jul-2008. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02236899 |
|---|---|
| Brand name | CHELATED CHROMIUM 200 MCG |
| Generic / active ingredient | CHROMIUM (CHROMIUM HVP CHELATE) : 200 MCG |
| Manufacturer | WN PHARMACEUTICALS LTD. |
| Strength | 200 MCG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A12CX OTHER MINERAL PRODUCTS |
| AHFS class | 88:29.00* ; See footnote |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 17-Jul-2008 |
| Original market date | 1998-06-26 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02236899 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2236899 |
| Brand name | CHELATED CHROMIUM 200 MCG |
| Active ingredient / INN | CHROMIUM (CHROMIUM HVP CHELATE) : 200 MCG |
| ATC code | A12CX |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A12 |
| AHFS class | 88:29.00* ; See footnote |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | WN PHARMACEUTICALS LTD. |
Which pack is which?
| Strength on the label | 200 MCG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code A12CX OTHER MINERAL PRODUCTS. 5 of 75 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MICRO CR | 4 MCG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00786985 |
| MICRO CU | 0.4 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00786969 |
| MICRO I | 100 MCG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED | DIN 01974548 |
| MICRO MN | 0.1 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00786942 |
| MICRO SE | 40 MCG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 01986007 |
| ACTI-I CAPLET | 0.225 MG | TABLET | ACTI-FORM LTD. | CANCELLED POST MARKET | DIN 00899127 |
| ACTICHROM | 200 MCG | TABLET | NUTRACEUTICAL CORPORATION | CANCELLED (UNRETURNED ANNUAL) | DIN 02241135 |
| ACTYFORM | 1 MG | CAPSULE | TECHNODIET S.E.N.C. | CANCELLED POST MARKET | DIN 02240282 |
| BIO-CHROME | 200 MCG | CAPSULE | SANTÉ NATURELLE (AG) LTÉE | CANCELLED POST MARKET | DIN 02241894 |
| BIO-PLEX TAB 0.95MG | .95 MG | TABLET | THERAPEUTIC FOODS CO. | CANCELLED POST MARKET | DIN 00760625 |
Who else supplies OTHER MINERAL PRODUCTS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OTHER MINERAL PRODUCTS appears in 8 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.